---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-091357"
form_type: "8-K"
ticker: "RMD"
cik: "0000943819"
company_name: "RESMED INC"
filed_at: "2025-04-23T23:59:59+00:00"
generated_at: "2026-05-23T08:51:59.932514+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# ResMed Q3 FY2025: revenue $1.29B (+8%), GAAP EPS $2.48 (+22%), non-GAAP EPS $2.37 (+11%)

## Summary
- Revenue of $1.29B (+8% YoY; +9% constant currency); GAAP diluted EPS $2.48 vs $2.04 (+22%).
- Gross margin improved 140 bps to 59.3%; non-GAAP gross margin 59.9%.
- Operating income up 14% to $426.3M; non-GAAP operating income up 13% to $444.6M.
- Operating cash flow of $579M in the quarter.
- Quarterly dividend of $0.53/share declared; payable June 12, 2025 to holders of record May 8, 2025.

## SEC filing metadata
- accession: 0001193125-25-091357
- form_type: 8-K
- ticker: RMD
- cik: 0000943819
- company_name: RESMED INC
- filed_at: 2025-04-23T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/943819/000119312525091357/0001193125-25-091357-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/943819/000119312525091357/d830100d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-091357
- JSON: https://secwatch.observer/filing/0001193125-25-091357.json
- Plain text: https://secwatch.observer/filing/0001193125-25-091357.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.